• About us
• Contact

Advertisement

Organisation › Details

Evonik (Group)

Evonik is one of the world leaders in specialty chemicals. The company is active in more than 100 countries around the world and generated sales of €13.1 billion and an operating profit (adjusted EBITDA) of €2.15 billion in 2019. Evonik goes far beyond chemistry to create innovative, profitable and sustainable solutions for customers. More than 32,000 employees work together for a common purpose: We want to improve life, day by day. *

 

	Start	2007-01-01 existent
	Today	Evonik Industries AG
	Industry	CHEMICALS
	Industry 2	specialty chemicals
	Person	Kullmann, Christian (Evonik 202206 CEO)
	Person 2	Engel, Klaus (Evonik 201112 Chairman of Executive Board)
	Region	Essen
	Country	Germany
	Street	1–11 Rellinghauser Str.
	City	45128 Essen
	Tel	+49-201-177-01
		Address record changed: 2020-12-02
Basic data	Employees	H: 10,001 to 50,00 (2019-12-31)
	Currency	EUR
	Annual sales	15,300,000,000 (sales, consolidated (2023) 2023-12-31)
		* Document for »About Section«: Evonik Industries AG. (3/17/20). "Press Release: Evonik Achieves Major Biotech Breakthrough with a New Animal-free and Fermentation-based Collagen Platform".
		Record changed: 2025-03-16

Advertisement

More documents for Evonik (Group)

• [1] Leon-Nanodrugs GmbH. (12/5/24). "Press Release: Feasibility Study with Evonik Confirms Leon’s FR-JET Technology’s Performance in Advanced Nanoparticle Manufacturing for Drug Delivery". Munich, Planegg....
• [2] Abolis Biotechnologies SAS. (9/12/24). "Press Release: Abolis Biotechnologies Secures 35 Mio. Euro from International Consortium of Industrials and Funds". Èvry-Courcouronnes....
• [3] Evonik. (2/20/24). "Press Release: Evonik Partners with the University of Mainz to Commercialize a New Class of PEG Lipids for Nucleic Acid Delivery". Essen....
• [4] Evonik Industries AG. (6/2/22). "Press Release: Evonik Invests US$220 Million in Partnership with the U.S. Government to Build New Lipid Production Facility for mRNA-based therapies in the U.S.". Essen & Parsipanny, NJ....
• [5] Hovione. (2/25/22). "Press Release: Jean-Luc Herbeaux to Become Hovione CEO". Lisbon....
• [6] Evonik Industries AG. (8/2/21). "Press Release: Evonik Acquires German Biotech Company JeNaCell to Expand Biomaterials Portfolio for New Medical Device Markets". Essen....
• [7] Evonik Industries AG. (6/10/21). "Press Release: Evonik and Stanford University Sign Research Collaboration – Evonik to Market and Develop New Drug Delivery Platform for mRNA and Gene Therapy". Essen....
• [8] Evonik Industries AG. (2/11/21). "Press Release: Evonik Strengthens Strategic Partnership with BioNTech on COVID-19 Vaccine". Essen....
• [9] Evonik. (12/7/20). "Press Release: Fight Against COVID-19. Evonik Supplies Key Technology for Gene-based Drugs". Essen....
• [10] Evonik Industries AG. (3/17/20). "Press Release: Evonik Achieves Major Biotech Breakthrough with a New Animal-free and Fermentation-based Collagen Platform"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.